TACSTD2 Antikörper (Middle Region)
Kurzübersicht für TACSTD2 Antikörper (Middle Region) (ABIN453439)
Target
Alle TACSTD2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Spezifität
- This antibody reacts to TACSTD2.
-
Aufreinigung
- Saturated Ammonium Sulfate (SAS) precipitation
-
Immunogen
- KLH conjugated synthetic peptide selected from the Center region of human TROP2
-
-
-
-
Applikationshinweise
-
ELISA: 1/1,000. Western blotting: 1/50 - 1/100.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- TACSTD2 (Tumor-Associated Calcium Signal Transducer 2 (TACSTD2))
-
Andere Bezeichnung
- TACSTD2
-
Hintergrund
- TROP2 is a carcinoma-associated antigen defined by the monoclonal antibody GA733. This antigen is a member of a family including at least two type I membrane proteins. It transduces an intracellular calcium signal and acts as a cell surface receptor. Mutations of its gene result in gelatinous drop-like corneal dystrophy, an autosomal recessive disorder characterized by severe corneal amyloidosis leading to blindness.Synonyms: GA733-1, M1S1, TROP2, Trop-2, Tumor-associated calcium signal transducer 2
-
Gen-ID
- 4070
-
NCBI Accession
- NP_002344
-
UniProt
- P09758
Target
-